SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-22
👔
Serina Therapeutics, Inc.
@SER_InsiderForm 4 Filing: Bailey Gregory Acquires $19.0M of $SER
INSIDER ACQUISITION
⚡ MATERIALITY: 5/10
corporate issuer
Serina Therapeutics, Inc.
Ticker: $SER
Transaction Value
$19.0M
Price/Share: $2.25
transaction date
2026-06-17
Shares: 8,437,472
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Bailey Gregory, holds the title of Director at Serina Therapeutics, Inc..
On 2026-06-17, the insider transacted 8,437,472 shares.The shares were transacted at a weighted average price of $2.25 per share, resulting in a total market-relevant value of $19.0M.
Executive Summary Summary
Bailey Gregory (Director) transacted $19.0M of $SER
Post-Transaction Position: 8,564,382 shares
SEC Accession No: 0001329505-26-000007 (CIK: 1329505)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.